A J Camm
Overview
Explore the profile of A J Camm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
644
Citations
7287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cohen A, Lip G, De Caterina R, Heidbuchel H, Zamorano J, Agnelli G, et al.
Vascul Pharmacol
. 2018 Apr;
106:9-21.
PMID: 29656119
Atrial fibrillation (AF) and venous thromboembolism (VTE) are cardiovascular conditions significant in contemporary practice. In both, the use of anticoagulation with vitamin K antagonists (VKAs) has been traditionally used to...
2.
Camm A, Savelieva I, Potpara T, Hindriks G, Pison L, Blomstrom-Lundqvist C
J Intern Med
. 2016 Mar;
279(5):412-27.
PMID: 27029018
The prevalence of atrial fibrillation (AF) in the general population is between 1% and 2% in the developed world and is higher in men than in women. The arrhythmia occurs...
3.
Hunter A, Cox A, DArcy J, Rooms M, Camm A
J R Army Med Corps
. 2015 Aug;
161(3):237-43.
PMID: 26246351
Atrial fibrillation (AF) is the most common sustained atrial arrhythmia, and increases an individual's risk of morbidity and mortality from cardiovascular and thromboembolic events. In this article, we review the...
4.
Steffel J, Giugliano R, Braunwald E, Murphy S, Atar D, Heidbuchel H, et al.
Eur Heart J
. 2015 May;
36(33):2239-45.
PMID: 25971288
Background: In the ENGAGE AF-TIMI 48 trial, the higher-dose edoxaban (HDE) regimen had a similar incidence of ischaemic stroke compared with warfarin, whereas a higher incidence was observed with the...
5.
Lewalter T, Kanagaratnam P, Schmidt B, Rosenqvist M, Nielsen-Kudsk J, Ibrahim R, et al.
Europace
. 2014 May;
16(5):626-30.
PMID: 24798956
Patients with atrial fibrillation (AF) are at an increased risk of ischaemic stroke. The efficacy of stroke prevention with vitamin K antagonists in these patients has been well established. However,...
6.
Boos C, Nam M, Camm A
Heart Fail Rev
. 2013 Jun;
19(3):391-401.
PMID: 23797696
Heart failure (HF) and atrial fibrillation (AF) frequently coexist and share a reciprocal relationship. The presence of AF increases the propensity to HF and can worsen its severity as well...
7.
Camm A, Lip G, De Caterina R, Savelieva I, Atar D, Hohnloser S, et al.
Europace
. 2013 Feb;
15(3):461-2.
PMID: 23430753
No abstract available.
8.
Camm A, Lip G, De Caterina R, Savelieva I, Atar D, Hohnloser S, et al.
Europace
. 2013 Feb;
15(3):460-1.
PMID: 23430752
No abstract available.
9.
Camm A, Savelieva I
J R Coll Physicians Edinb
. 2012 Apr;
42 Suppl 18:23-34.
PMID: 22518391
The fundamental management strategy for atrial fibrillation (AF) is still debated. There is no doubt that those patients at risk of thromboembolic events should be offered anticoagulant therapy. However, it...
10.
Kiotsekoglou A, Sutherland G, Moggridge J, Nassiri D, Camm A, Child A
Heart
. 2009 Feb;
95(19):1561-6.
PMID: 19224905
Use of echocardiography has dramatically changed the way in which patients with Marfan syndrome are diagnosed, monitored and treated. Owing to the lethal nature of aortic complications, priority has been...